WALTHAM, Mass., April 3 /PRNewswire-FirstCall/ -- Thermo Fisher
Scientific Inc. (NYSE: TMO), the world leader in serving science, today
announced that it has completed the sale of its Genevac business, a
manufacturer of vacuum concentrators, to private equity firm Riverlake
Equity Partners, LP. Riverlake intends to eventually merge Genevac into its
laboratory equipment products and services company, SP Industries, Inc.
On November 9, 2006, Thermo Electron Corporation merged with Fisher
Scientific International Inc. to form Thermo Fisher Scientific. The
European Commission (EC) and the Federal Trade Commission (FTC) required
the divestiture of Genevac, a $17 million business of Fisher Scientific, as
the sole condition to their approval of the merger. Under the terms of the
FTC Decision and Order, and the Commitments to the European Commission,
Thermo Fisher Scientific was required to divest the business to a buyer
approved by the FTC and EC by April 9, 2007.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in
serving science, enabling our customers to make the world healthier,
cleaner and safer. With an annual revenue rate of more than $9 billion, we
employ 30,000 people and serve over 350,000 customers within pharmaceutical
and biotech companies, hospitals and clinical diagnostic labs,
universities, research institutions and government agencies, as well as
environmental and industrial process control settings. Serving customers
through two premier brands, Thermo Scientific and Fisher Scientific, we
help solve analytical challenges from routine testing to complex research
and discovery. Thermo Scientific offers customers a complete range of
high-end analytical instruments as well as laboratory equipment, software,
services, consumables and reagents to enable integrated laboratory workflow
solutions. Fisher Scientific provides a complete portfolio of laboratory
equipment, chemicals, supplies and services used in healthcare, scientific
research, safety and education. Together, we offer the most convenient
purchasing options to customers and continuously advance our technologies
to accelerate the pace of scientific discovery, enhance value for customers
and fuel growth for shareholders and employees alike. Visit
http://www.thermofisher.com.
Media Contact Information:
Lori Gorski
Phone: 781-622-1242
E-mail: lori.gorski@thermofisher.com
Website: http://www.thermofisher.com
Investor Contact Information:
Ken Apicerno
Phone: 781-622-1111
E-mail: ken.apicerno@thermofisher.com
SOURCE Thermo Fisher Scientific Inc.
 back to top
Related links:
http://www.thermofisher.com/
http://www.prnewswire.com/comp/877850.html/
CONTACT:
Media, Lori Gorski, +1-781-622-1242,
lori.gorski@thermofisher.com; Investors, Ken Apicerno,
+1-781-622-1111, ken.apicerno@thermofisher.com
|
